Are Research Peptides Australia and Brain Skin Bioregulators effective for cognitive wellness?

Dosing AOD-9604: A Guide to Timing and Synergy in Weight Management Protocols

June 8, 2026 infa sense

What Exactly is AOD-9604?

Scientifically classified as a C-terminal fragment of Human Growth Hormone (specifically residues 176–191), AOD-9604 was designed to isolate the fat-burning properties of HGH without the unwanted side effects. Unlike full-spectrum HGH, AOD does not increase IGF-1 levels or mess with your blood sugar.

Its primary mission? Revolutionize fat metabolism by stimulating lipolysis (the breakdown of fat) and inhibiting lipogenesis (the transformation of non-fat foods into body fat). In the research space, it’s often referred to as the “Anti-Obesity Drug,” which is exactly where it gets its name.

The “Fasted Window”: Why Timing is Everything

If there is one thing you take away from this guide, let it be this: Insulin is the enemy of AOD-9604.

For AOD to effectively bind to the receptors on adipose tissue and trigger fat mobilization, insulin levels must be low. If your research subject has recently eaten: especially carbohydrates: the resulting insulin spike will effectively “lock” the fat cells, making the peptide nearly useless.

The Gold Standard Protocol:

  1. Morning Fasted: Administer the research dose immediately upon waking.
  2. The Wait: Do not introduce calories for at least 60 to 90 minutes post-administration.
  3. The Cardio Spike (Optional): Many researchers find that performing steady-state cardio during this fasted window “combusts” the fat that AOD has just mobilized into the bloodstream.

A sleek, modern digital clock showing 6:00 AM placed next to a glass of water and a clinical peptide kit, emphasizing early morning fasted administration, soft morning sunlight.